Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
44.28
-0.28 (-0.63%)
At close: Apr 3, 2025, 4:00 PM
44.37
+0.09 (0.20%)
After-hours: Apr 3, 2025, 7:55 PM EDT

Exact Sciences Statistics

Total Valuation

Exact Sciences has a market cap or net worth of $8.23 billion. The enterprise value is $9.96 billion.

Market Cap 8.23B
Enterprise Value 9.96B

Important Dates

The next confirmed earnings date is Thursday, May 1, 2025, after market close.

Earnings Date May 1, 2025
Ex-Dividend Date n/a

Share Statistics

Exact Sciences has 185.76 million shares outstanding. The number of shares has increased by 2.25% in one year.

Current Share Class 185.76M
Shares Outstanding 185.76M
Shares Change (YoY) +2.25%
Shares Change (QoQ) +0.28%
Owned by Insiders (%) 0.75%
Owned by Institutions (%) 100.09%
Float 184.25M

Valuation Ratios

PE Ratio n/a
Forward PE 129.27
PS Ratio 2.96
Forward PS 2.64
PB Ratio 3.42
P/TBV Ratio n/a
P/FCF Ratio 110.34
P/OCF Ratio 39.07
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 334.77, with an EV/FCF ratio of 133.65.

EV / Earnings n/a
EV / Sales 3.61
EV / EBITDA 334.77
EV / EBIT n/a
EV / FCF 133.65

Financial Position

The company has a current ratio of 2.15, with a Debt / Equity ratio of 1.16.

Current Ratio 2.15
Quick Ratio 1.76
Debt / Equity 1.16
Debt / EBITDA 38.74
Debt / FCF 37.24
Interest Coverage -6.85

Financial Efficiency

Return on equity (ROE) is -37.09% and return on invested capital (ROIC) is -2.12%.

Return on Equity (ROE) -37.09%
Return on Assets (ROA) -1.87%
Return on Invested Capital (ROIC) -2.12%
Return on Capital Employed (ROCE) -3.56%
Revenue Per Employee $394,124
Profits Per Employee -$146,980
Employee Count 7,000
Asset Turnover 0.44
Inventory Turnover 5.80

Taxes

Income Tax -7.30M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -39.95% in the last 52 weeks. The beta is 1.14, so Exact Sciences's price volatility has been higher than the market average.

Beta (5Y) 1.14
52-Week Price Change -39.95%
50-Day Moving Average 49.02
200-Day Moving Average 55.76
Relative Strength Index (RSI) 42.20
Average Volume (20 Days) 1,960,854

Short Selling Information

The latest short interest is 10.60 million, so 5.71% of the outstanding shares have been sold short.

Short Interest 10.60M
Short Previous Month 10.66M
Short % of Shares Out 5.71%
Short % of Float 5.75%
Short Ratio (days to cover) 4.05

Income Statement

In the last 12 months, Exact Sciences had revenue of $2.76 billion and -$1.03 billion in losses. Loss per share was -$5.59.

Revenue 2.76B
Gross Profit 1.92B
Operating Income -185.10M
Pretax Income -172.10M
Net Income -1.03B
EBITDA 29.76M
EBIT -185.10M
Loss Per Share -$5.59
Full Income Statement

Balance Sheet

The company has $1.04 billion in cash and $2.78 billion in debt, giving a net cash position of -$1.74 billion or -$9.35 per share.

Cash & Cash Equivalents 1.04B
Total Debt 2.78B
Net Cash -1.74B
Net Cash Per Share -$9.35
Equity (Book Value) 2.40B
Book Value Per Share 12.94
Working Capital 839.24M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $210.54 million and capital expenditures -$135.99 million, giving a free cash flow of $74.55 million.

Operating Cash Flow 210.54M
Capital Expenditures -135.99M
Free Cash Flow 74.55M
FCF Per Share $0.40
Full Cash Flow Statement

Margins

Gross margin is 69.55%, with operating and profit margins of -6.71% and -37.29%.

Gross Margin 69.55%
Operating Margin -6.71%
Pretax Margin -37.56%
Profit Margin -37.29%
EBITDA Margin 1.08%
EBIT Margin -6.71%
FCF Margin 2.70%

Dividends & Yields

Exact Sciences does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.25%
Shareholder Yield -2.25%
Earnings Yield -12.51%
FCF Yield 0.91%
Dividend Details

Analyst Forecast

The average price target for Exact Sciences is $70.59, which is 59.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target $70.59
Price Target Difference 59.42%
Analyst Consensus Strong Buy
Analyst Count 18
Revenue Growth Forecast (5Y) 10.09%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Exact Sciences has an Altman Z-Score of 1.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.32
Piotroski F-Score 3